Author: Blondin, A.
Paper Title Page
FRM1CIO03 IBA-JINR 400 MeV/u Superconducting Cyclotron for Hadron Therapy 404
 
  • N.A. Morozov, V. Aleksandrov, S. Gurskiy, G.A. Karamysheva, N.Yu. Kazarinov, S.A. Kostromin, E. Samsonov, V. Shevtsov, G. Shirkov, E. Syresin, A. Tuzikov
    JINR, Dubna, Moscow Region, Russia
  • M. Abs, A. Blondin, Y. Jongen, W.J.G.M. Kleeven, D. Vandeplassche, S. Zaremba
    IBA, Louvain-la-Neuve, Belgium
  • O. Karamyshev
    JINR/DLNP, Dubna, Moscow region, Russia
 
  The compact superconducting isochronous cyclotron C400 [1] has been designed by the IBA-JINR collaboration. It will be the first cyclotron in the world capable of delivering protons, carbon and helium ions for cancer treatment. The cyclotron construction is started this year within the framework of the ARCHADE project [2] (Caen, France). 12C6+ and 4He2+ ions will be accelerated to 400 MeV/u energy and extracted by the electrostatic deflector, H2+ ions will be accelerated to the energy of 265 MeV/u and extracted by stripping. The magnet yoke has a diameter of 6.6 m, the total weight of the magnet is about 700 t. The designed magnetic field corresponds to 4.5 T in the hills and 2.45 T in the valleys. Superconducting coils will be enclosed in a cryostat; all other parts of the cyclotron will be warm. Three external ion sources will be mounted on the switching magnet on the injection line located below the cyclotron. The main parameters of the cyclotron, its design, the current status of the development work on the cyclotron systems are presented.
[1] Y.Jongen et al, 'IBA C400 Cyclotron Project for Hadron Therapy', The 18th International Conference on Cyclotrons and their Applications Cyclotrons 2007, Italy 2007.
[2] http://archade.fr/
 
slides icon Slides FRM1CIO03 [1.996 MB]